Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advanz Pharma Corp.

concordiarx.com

Latest From Advanz Pharma Corp.

Advanz Has Six Deals In The Works As It Cuts Its Losses

Advanz Pharma’s business development team is busty assessing potential deals as the recapitalized company works towards restoring profitability on an eroding revenues base.

M & A Deals

UK's CMA Goes After Advanz, Morningside And Alliance On Nitrofurantoin

The UK’s Competition and Markets Authority has issued a statement of objections to Advanz, Morningside and wholesaler Alliance Healthcare after provisionally finding that the firms broke competition law by arranging to carve up the UK market for nitrofurantoin.

 

Compliance Generic Drugs

UK's CMA Goes After Advanz, Morningside And Alliance On Nitrofurantoin

The UK’s Competition and Markets Authority has issued a statement of objections to Advanz, Morningside and wholesaler Alliance Healthcare after provisionally finding that the firms broke competition law by arranging to carve up the UK market for nitrofurantoin.

Compliance Regulation

Advanz Seeks Product Ideas From Within And From Outside

Niche established medicines specialist Advanz Pharma is encouraging its own staff to come up with product ideas as it continues to seek drugs to license or acquire from third parties in a bid to kickstart its pipeline.
Value-Added Medicines Business Strategies
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register